Why it matters: This paper is a "must-read" for anyone who cares about Alzheimer's disease. We often think of the emotional toll the disease can take, but this piece weighs how economics can impact innovations related to prevention, medicines and delivery of care. Even if you don't have time to read the whole paper, the abstract might make you think about aspects of Alzheimer's you've never considered.
The cognitively
challenged consumer: One of the many interesting elements
this paper explores is how the law and market pressures might drive how
companies treat cognitively challenged consumers. There are loads of laws that
address how companies must treat physically challenged consumers, but not too
many that deal with the treatment of the cognitively challenged.
Full Story: Harvard
Business School Working Knowledge (9/28)
No comments:
Post a Comment